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The choroid plexus (CP) plays a major role in controlling the entry of substances and
immune cells into the brain as it forms the blood-cerebrospinal fluid barrier (BCSFB)
in the brain ventricles. Dysregulated immune cell trafficking through the epithelial cell
(EC) layer of CP is central for the pathogenesis of infectious diseases in the brain and
many neurodegenerative disorders. In vitro studies elucidating the function of the CP
have so far been limited to the monolayer culture of CP ECs. To mimic immune cell
migration across the CP barrier, a three-dimensional model would be advantageous.
Here, we present an in vitro platform for studies of the immune cell trafficking based on
CP explants/organoids. The explants were generated from fragments of mouse CPs in
Matrigel, where the cells formed luminal spaces and could be maintained in culture for
at least 8 weeks. We demonstrate expression of the major CP markers in the explants,
including transthyretin and aquaporin 1 as well as ZO1 and ICAM-1, indicating a capacity
for secretion of cerebrospinal fluid (CSF) and presence of tight junctions. CP explants
displayed CP-like cell polarization and formed an intact EC barrier. We also show that
the expression of transthyretin, transferrin, occludin and other genes associated with
various functions of CP was maintained in the explants at similar levels as in native CP.
By using dendritic cells and neutrophils, we show that the migration activity of immune
cells and their interactions with CP epithelium can be monitored by microscopy. Thereby,
the three-dimensional CP explant model can be used to study the cellular and molecular
mechanisms mediating immune cell migration through CP epithelium and other functions
of choroid EC. We propose this platform can potentially be used in the search for
therapeutic targets and intervention strategies to improve control of (drug) substances
and (immune) cell entry into the central nervous system.
Keywords: in vitro model, tight junction markers, immune cells, choroid plexus, epithelium, organoid, explant,
blood-cerebrospinal fluid barrier
Abbreviations: Ara-C, Cytosine arabinoside; BCSFB, Blood-cerebrospinal fluid barrier; CFSE, Carboxyfluorescein
succinimidyl ester; CP, Choroid Plexus; CSF, cerebrospinal fluid; DCs, Dendritic cells; Neut, Mouse neutrophils; PBMCs,
Peripheral blood mononuclear cells.
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INTRODUCTION
The choroid plexus (CP), located in each of the brain ventricles,
produces the cerebrospinal fluid (CSF), controls the access
of substances and immune cells from the blood to the CSF
and transfers substances from the CSF to the blood. Together
with the arachnoid membrane, it forms the blood-cerebrospinal
fluid barrier (BCSFB). Transthyretin (TTR) and transferrin play
key roles in the production of CSF by the CP epithelium
(Stauder et al., 1986; Strazielle and Ghersi-Egea, 2000). The
CP is composed of a monolayer of specialized epithelial cells
(ECs), enveloping capillaries formed by fenestrated endothelial
cells. The capillaries in the CP allow free movement of
molecules across the endothelial cell layer through fenestrations
and intercellular gaps, which differs from the non-fenestrated
continuous endothelium found elsewhere in the brain, where
only smaller molecules such as water and ions are allowed to
pass through intercellular clefts. The tight and adherent junctions
of the CP epithelium are essential for the blood-CSF barrier
function and the tightness of the epithelium determines the
passive and active transport of molecules. The tight junctions
are characterized by expression of zona occludens (ZO1),
claudin proteins, ICAM-1 and VCAM (Bauer et al., 2014)
and are central for the controlled passage of blood cells and
immune cells across the BCSFB (Anderson and Van Itallie,
1995; Engelhardt and Sorokin, 2009). For selected immune
cells, such as macrophages and dendritic cells (DCs), the CP
allows regular crossing of the barrier as part of normal immune
surveillance (Meeker et al., 2012). This process is restricted
and tightly regulated. For many infectious diseases in the
brain, pathogen entry through CP has been suggested, however,
the mechanisms are not clear, partly due to the inability to
study such interactions in vitro (Ghersi-Egea et al., 2018). It
has been suggested that immune cells performing surveillance
in the CP may directly be involved in viral infections and
autoimmune processes (Meeker et al., 2012). Recent advances
in understanding immune functions of CP call for a more
sophisticated BCSFB model to investigate structure, function
and barrier properties of the epithelial layer of CP. Several
in vitro models have been invented and used for studies on
CP structure and function—primary CP fragments (Inoue et al.,
2015), monolayers (Baehr et al., 2006; Monnot and Zheng, 2013)
and clusters (Sandrof et al., 2017). However, in these systems, the
functions of CP cannot be easily monitored, as the functionality
of the tissue depends on the ability to maintain 3D structure
(Redzic, 2013; Takebe and Wells, 2019), i.e., appropriate cell
polarization allowing formation of the lumen and thereby intact
EC barrier. Cerebral organoids (Lancaster and Knoblich, 2015;
Watanabe et al., 2017) are a recently developed advanced system,
where induced pluripotent stem cells (iPSC) from human skin,
are differentiated into a brain-like structure by ‘‘guidance’’
with specific growth factors. However, these cultures are not
easily applied for studies using transgenic mouse material and
individual mouse tissue comparison, as well as close monitoring
of CP epithelium.
Here, we report a novel method for generation of dissociated
CP explants, or CP fragment-derived organoid, from mice
with essential morphology and characteristics of BCSFB, which
we validate by immunostainings for CP markers, qPCR
analysis and by monitoring interactions of immune cells with
CP explants.
MATERIALS AND METHODS
Animals
C57BL/6J mice were purchased from Charles River. Explants
were generated from four to six mice per isolation. All animal
experiments were approved by the Danish Animal Inspectorate
(2018-15-0201-01442).
Explant Generation
Non-fasted 8–10-week-old mice were euthanized by cervical
dislocation, the skin on the back of the head and neck was
sterilized with 70% ethanol and the brain was exposed using
scissors, bone cutter, and fine forceps. The brain was excised
and immersed in 10 ml of artificial CSF (aCSF) for 10 min
to wash off the blood excess. The composition of aCSF was
the following: 120 mM NaCl, 2.5 mM KCl, 1 mM NaH2PO4,
1.3 mM MgSO4, 17 mM Na-Hepes, 2, 5 mM CaCl2 and 10 mM
glucose. The pH was adjusted to 7.4 with HCl. The CP from
both lateral, third and fourth ventricles was dissected under
a light microscope and immersed in 0.5 ml of aCSF on ice
(Figure 1A). The procedure was repeated with the remaining
three to five mice and the CP tissues were pooled in the 0.5 ml
of the aCSF (Figure 1B). When all the tissues were collected,
they were minced with a pair of fine ophthalmologic scissors
for 5 min to produce roughly 1-mm cubes. After mincing, the
total volume was brought up to 1 ml by the addition of 0.5 ml
aCSF. The tube contents were briefly spun and the supernatant
was removed.
FIGURE 1 | (A) Location of the choroid plexus (CP) in the ventricles of the
mouse brain. (B) Mouse CP excised from the lateral ventricles (bar 100 µm).
The right panel shows a magnified view (bar 20 µm). (C) Fragments of CP
after trypsin digestion. Representative image of a primary CP cell cluster in
Matrigel at day 0 (bar 50 µm). (D) Example of a small CP explant at day 2 (bar
20 µm). (E) Example of a CP explant at day 6 (bar 20 µm). Arrows show
luminal spaces.
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Tissue Digestion
Digestion solution contained 0.25% trypsin (Life Technologies)
in aCSF, and 1 mol/l EDTA (Life TechnologiesTM), freshly
prepared and kept on ice until use. One milliliter of digestion
solution was added to the tube’s contents and mixed by gently
tapping the tube. The supernatant was aspirated using a pipette
and 1–2 ml of digestion solution was added. The tube was
incubated at 37◦C for 15–20 min with gentle pipetting with
a plastic Pasteur pipette every 5 min. After the digestion, the
tissue was further dispersed by gentle pipetting and checked
under a microscope for the presence of small fragments of CP
(Figure 1C). The digestion was stopped by adding 4ml of DMEM
containing 5% fetal bovine serum (FBS) to the digestion mixture
and filtered through a 70 µm filter. The tube was centrifuged
at 300× g for 5 min at 4◦C in a 1.5 ml sterile tube. The
supernatant was discarded and the pellet was washed once more
with DMEM containing 5% FBS by resuspension and centrifuged
again. At this point, the pellet contained clusters of primary
EC ranging from 20 to 50 µm. The pellet was resuspended
in 200 µl of growth medium (the amount is given per pooled
four CPs), containing DMEM with 5% FBS, supplemented
with HEPES, L-glutamine (Sigma) and primocin 1:500 (Thermo
Fisher Scientific), 1 µg/ml EGF (Peprotech), 1 µg/ml FGF10
(Peprotech), 1 µg/ml IGF1 (Peprotech), and 1:200 B27 (Life
Technologies). A 20 µl aliquot of cell suspension was mixed
with 20 µl of 0.4% trypan blue to count cell numbers and to
assess the viability. The ice-cold contents of the tube were mixed
with 200 µl of Matrigel (growth factor reduced, from Corning)
and 20–50 µl of the suspension was distributed in the center
in each well of a 24-well glass-bottomed plated (Corning). The
growth medium was added to the wells after the Matrigel domes
solidified. The plate was then placed in a humidified incubator
with 95% air/5% CO2 at 37◦C. The growth medium was used
during the first 6 days of culture. Every two days, half of the
medium volume was replaced with fresh growth medium. On
the second day, 20 µM cytosine arabinoside (Ara-C) was added
to the culture medium. After 6 days, the explants were re-plated
in fresh Matrigel to eliminate cell debris and blood vessels,
and to further dissociate large tissue fragments to allow explant
formation. The explants were released fromMatrigel by pipetting
and embedded in fresh Matrigel every following 6–10 days.
Ara-C treatment was applied in every passage for 48 h to
maintain fibroblast-free cultures. After the re-plating (passaging)
the cultures were maintained in the growth medium, but three
days before the experiments, FBS was omitted from the medium
composition to promote cell maturation (Hakvoort et al., 1998;
Barkho and Monuki, 2015). We maintained the cultures for at
least 8 weeks. The procedure for explant generation is presented
in Figure 2.
Staining of Explants in Whole-Mount
Preparations
For immunostainings, the medium was removed and explants
were first fixed in 0.5 ml of 4% PFA in each well at 4◦C
for 30 min. After that, the explants were washed with PBS at
room temperature during 10 min three times and treated with
FIGURE 2 | Flow chart for the generation of CP explants.
the permeabilization buffer containing 0.15% Triton X-100 in
PBS. Next, the samples were blocked with 2% BSA for 60 min
and incubated with the primary antibodies overnight at 4◦C.
Anti-transthyretin (anti-TTR; Santa Cruz) was used at 1:500,
anti-aquaporin 1 (AQ-1) and anti-ZO1 (both from Abcam)
were used at 1:200 dilution. After washing three times with
PBS (10 min per wash), the samples were incubated with the
secondary antibody Alexa Fluor 488 diluted 1:500 and DAPI
for 1 h at 37◦C. After washing with PBS, the samples were
examined using confocal microscopy. Fragments of isolated CP
fixed in 4% PFA were used as a positive control. Phalloidin
Alexa Fluor 647 was applied in fixed wholemount preparations
according to the manufacturer’s instructions for 15 min and
washed with PBS before viewing. Images were acquired on a
confocal Leica 780 microscope and processed using Zen software
and ImageJ. Immunostainings were performed on two wells for
each antibody on two batches of explants derived from material
from three to five mice.
RT-PCR Analysis
Explants were washed with cold PBS and collected from
wells together with Matrigel, transferred to a 1.5 ml conical
bottomed tube and pipetted to disrupt Matrigel. Then the tube
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TABLE 1 | Quantitative transcription-polymerase chain reaction (RT-PCR) mouse primers.
Gene Alias Forward Reverse
Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Ywhaz AGA CGG AAG GTG CTG AGA AA GAA GCA TTG GGG ATC AAG AA
Transthyretin Ttr AGCCCTTTGCCTCTGGGAAGAC TGCGATGGTGTAGTGGCGATGG
Matrix metallopeptidase 9 Mmp9 AAGGACGGCCTTCTGGCACACGCCTTT GTGGTATAGTGGGACACATAGTGG
Prostaglandin D2 synthase (brain) Ptdgs GGGAATCCCAAGAGACCCAG GCTCTGAGCAAATGGCTGC
Occludin Ocln ATGACTTCAGGCAGCCTCGTTACA TCAGCAGCAGCCATGTACTCTTCA
Transferrin Tf GGAAGACTCTGCTTTGCAGCTAT GCCCAGGTAGCCACTCATGA
Creatine kinase brain Ckb GGAATCCTCACCTGGGCT GGCAGGCCAAACCCTAGT
Insulin-like growth factor IGF-2 GTCGATGTTGGTGCTTCTCA AAGCAGCACTCTTCCACGAT
G protein-coupled receptor 125 GPR125 TTT CTG ACT ATG GGC GAA GG GCC TCC ATG ATG GTG TTC TT
Related to methods.
was briefly spanned and the supernatant was removed. Total
RNA was extracted from the explants or isolated CP (as a
positive control) using the RNeasy Micro Kit (Qiagen) according
to the manufacturer’s instructions. The cDNA synthesis was
performed on 100 ng of total RNA, using Superscript III
reverse transcriptase with oligo dT primers according to
the manufacturer’s instructions (Invitrogen, Thermo Fisher
Scientific). Quantitative real-time PCR was performed using the
QuantStudio 6 Flex Real-Time PCR System (Thermo Fisher
Scientific) and SYBR green assays with primers at 10 nM
was used according to manufacturer’s instructions. Each gene
expression was tested in three explant lines (biological replicates)
generated from nine mice in independent experiments. The
individual measurements were averaged from triplicated qPCR
wells (technical replicates). Cycle threshold (Ct) values were
obtained using the QuantStudio Real-time PCR Software, and
the∆-∆Ct method was used to calculate the relative fold change
of cDNA levels compared to the reference gene (Ywhaz). Primer
sequences are presented in Table 1.
Immune Cell Migration Studies
For a demonstration of immune cell interaction with CP
explants, we tested two immune cell types: Mouse neutrophils
(MN) and human DCs. DCs were obtained from human
blood as described previously (Jørgensen et al., 2018). In
brief, DCs were prepared from human peripheral blood
mononuclear cells (PBMCs) isolated from buffy coats (obtained
from healthy donors), by centrifugation on a Lymphoprep
gradient (STEMCELL technologies). Monocytes were isolated
from PBMC by plastic adherence. Adhered monocytes were
subsequently cultured and differentiated into immature DCs by
incubation with IL-4 (250 U/ml) and GM-CSF (1,000 U/ml) for
6 days, followed by activation into mature DCs by incubation
with 1,000 U/ml IL-6, 1,000 U/ml IL-1β, 1,000 U/ml TNF-α
(all from Peprotech), and 1 µg/ml PGE2 (from Sigma) for an
additional 2 days in the same medium. Before the experiment,
frozen DC was thawed in a water bath at 37◦C and washed
with warm X-Vivo 15 medium (Lonza) supplemented with
2% human AB serum and glutamine (both from Sigma), spun
down and resuspended in fresh medium to remove DMSO.
MN were prepared from 400 µl of peripheral mouse blood, by
adding 10 ml of distilled water, quickly mixing and adding 2X
concentrated HBSS supplemented with 10% FBS. The following
purification was done as described earlier (Swamydas et al.,
2015), using density gradient centrifugation with Histopaque
1077 and 1119 (Sigma). DCs and MNs were then labeled with
1 µM fluorescent marker carboxyfluorescein succinimidyl ester
(CFSE; Cell Labeling Kit, Abcam) in the experiment medium
during 5 min and washed with fresh medium. Explant and
immune cell suspension (20,000 cells per well) were mixed into
an aliquot of Matrigel (1:1) together with a combination of
human interleukin 6, interleukin 1 and TNFα (all at 1,000 U/ml)
and distributed in a 48-well glass-bottom plate as 20 µl drops.
The plated material was allowed to solidify at 37◦ C for
5 min before the experiment medium was added. The plate
was transferred to a confocal microscope for monitoring. The
bright field and fluorescence images at 488 nm throughout
the explant volume were taken every 2 min during the first
4 h. Alternatively, a time-lapse was recorded during 24 h in a
wide-field microscope and the explants were examined after the
time-lapse under a confocal microscope to evaluate the number
of transmigrating cells. The immune cells in similar experiments
have been shown to display activity for 48 h in our earlier studies
(Sebrell et al., 2019). Each explant was imaged as a z-stack and
every plane was examined to ensure the location of immune
cells. A representative image of the experimental setup showing
CP explant and interaction with fluorescence-labeled immune
cells is presented in Figure 3. The explants were loaded with
CFSE as described for DC labeling, washed, incubated with fresh
medium for 30 min and monitored in a microscope for 3 h. The
mean fluorescence intensity was measured over the lumen area
on the images using ImageJ. Organoid images were acquired on a
confocal microscope with an optical slice thickness of 3 µm with
3 µm between the sections. The measurements were performed
on the section with the largest organoid diameter over the 3 h
of the experiment. We did not observe significant changed in
the lumen area during the observation period. The acquisition
settings, such as exposure time, laser intensity and gain, were not
changed during the experiment.
Statistics
Quantitative results are presented as mean values with standard
error of the mean (SEM). A comparison of two groups was
performed by the Wilcoxon rank-sum test. For statistics, we
used R: A language and environment for statistical computing.
R Foundation for Statistical Computing, Vienna, Austria1.
1https://www.R-project.org/
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FIGURE 3 | Experimental design for testing the immune cell activity towards
the explants (white arrow). Dendritic cells (DCs) are labeled green with
fluorescent marker carboxyfluorescein succinimidyl ester (CFSE; black
arrows; bar 20 µm).
qPCR data were analyzed using Wilcoxon matched-pairs signed
rank-test to compare the data from different explant lines.
P-values less than 0.05 were considered significant (*< 0.05;
**< 0.01; ***< 0.001).
RESULTS
CP Explants Display Markers of CP
Epithelial Cells
CP cell clusters formed cyst-like structures starting from day
2 and onward (Figures 1C–E), following typical organoid
formation (Dahl-Jensen and Grapin-Botton, 2017). Explants
were formed with high efficiency as nearly all fragments
developed cystic structures and could be maintained for at
least 8 weeks with re-plating in fresh Matrigel every 6–10 days.
The explants had one or several well-defined cavities or
‘‘lumens’’ (Figures 1D,E). The explant size at this point
was ranging from approximately 50 to 400 µm, depending
on the initial digestion efficiency. The explant shape varied
significantly, as explants were forming multiple lumens of
smaller size or one lumen of larger size. We have not
observed major differences in the explant size or shape between
the batches. Immunostaining for specific choroid epithelium
markers TTR, AQ-1, ZO1 (zonula occludens) and claudin 3
(Stauder et al., 1986; Ghersi-Egea et al., 2018), showed positive
labeling in all cells constituting explants (Figures 4A–D). We
performed immunostaining for ICAM-1 as one of the major
and specific CP markers of tight junctions (Steffen et al.,
1996). Although many cells appeared flattened, possibly due to
quick filling up of the lumen with CSF, they were polarized
and demonstrated positive immunostaining for ICAM-1 on
the apical cell membranes (Figure 4E). F-actin filaments are
associated with tight junctions on the apical surface and directly
involved in controlling paracellular permeability (Anderson and
Van Itallie, 1995). To visualize F-actin distribution in explants,
FIGURE 4 | CP explants show typical CP markers. (A–E) Presence of
transthyretin (TTR), aquaporin 1 (AQ1), ZO1, Claudin 3 and ICAM-1 with DAPI
(blue) staining in CP explants. White arrows indicate the localization of the
staining on the apical or basolateral cell membrane (bar 20 µm). Optical
thickness of images sections 3 µm. (F) Distribution of F-actin (cyan) detected
by phalloidin in ex vivo CP fragment and explants (G). (H) E-cadherin staining
in a CP explant. (I) Expression of the CP epithelial markers, Ttr, lipocalin-type
prostaglandin D Synthase (Ptgds), transferrin (Tf ), creatine kinase brain (Ckb),
occludin (Ocln), insulin-like growth factor 2 (IGF-2) and G protein-coupled
receptor 125 (GPR125) in native mouse CP (white bars) and CP explant at
day 12 (black bars). n = 3 for explant series and n = 4 for CP fragments.
we used phalloidin 677 (Invitrogen). As Figures 4F,G show,
the staining was more pronounced on the inner surface of
the explants (Figure 4G), than on the outer surface, while
in primary CP tissue it was mostly localized on the outer
surface of fragments (Figure 4F; facing the ventricle lumen
in vivo). This confirmed that the apical side was facing the
explant lumen. The main structural differences and similarities
of native CP tissue and CP-fragment derived explants are
schematically presented in Figure 7. Similar cell polarization
has been observed in other types of organoids, mimicking
hollow organs, such as intestinal organoids (Fatehullah et al.,
2013; Petersen et al., 2018). Consistent with this, E-cadherin
labeling was localized to the basolateral side (Figure 4H). Thus,
CP explants were capable of self-organizing into polarized
cell layers and forming their lumen with an intact epithelial
barrier, the presence of which is supported by the retention
of fluorescent dye CFSE inside of explants (Supplementary
Figures S1A,B).
The expression of key CP markers determined by reverse
transcription-polymerase chain reaction (RT-PCR) was
compared in the explants from passage 2 (day 12) and native
CP tissues. We chose markers previously identified as highly
expressed in CP (Marques et al., 2011): Ttr and transferrin
(Tf ), as well as the major protein of the CSF, lipocalin-type
prostaglandin D Synthase (Ptgds), the creatine kinase brain type
(Ckb), important for creatine phosphorylation, and insulin-like
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growth factor 2 (IGF-2; Péraldi-Roux et al., 1990; Blödorn et al.,
1996; Marques et al., 2011; Lun et al., 2015). The expression
of occludin (Ocln) and matrix metallopeptidase 9 (Mmp9),
important for the maintenance of tight junctions (Martins
et al., 2011), was also determined as well as the expression
of GPR125, an adhesion G protein-coupled receptor highly
expressed in CP EC (Pickering et al., 2008) and recently shown
to be constitutively internalized (Spiess et al., 2019). Our
data show that these markers were expressed in explants
and ex vivo CP at similar levels (Figure 4I), indicating
that the CP EC maintained their identity in the applied
culture conditions.
Improved CP Explant Culture Efficiency
With Serum
To maximize the efficiency of CP explant cultures, we used
FBS to stimulate proliferation and cytosine arabinoside (Ara-
C) to avoid fibroblast proliferation. Addition of FBS showed
a pronounced positive effect on cell growth (Figure 5A), in
agreement with published work (Barkho and Monuki, 2015).
While, Ara-C treatment resulted in few immunopositive cells,
determined by anti-vimentin staining, indicating low numbers
of mesenchymal cells in explant cultures (Figure 5B). After
9 days of culture with FBS, the culture medium was changed
FIGURE 5 | (A) The addition of FBS increases the CP explant growth (bar 20 µm). (B) Ara-C-treated CP explants show very few fibroblasts labeled by vimentin
immunostaining (bar 10 µm). (C) CP ex cultured for 12 days. FBS was withdrawn during the last 3 days. (D,E) CP explants plated in 20% and 50% Matrigel on day
25. Panel to the right shows a magnified view of the epithelial cells (ECs), lumen (L) and accumulation of cell debris (CD) in the lumen (bar 20 µm).
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FIGURE 6 | Interaction of human dendritic cells (DCs) with CP epithelium. (A) A representative migration experiment with human DCs interacting with the CP
explant (bar 10 µm). Time series shows one of the DCs crossing into the lumen space. The last 35 min of the total of 100 min of the experiment are shown.
(B) Human DCs labeled with CFSE (green) migrate into the lumen (white arrow). Endpoint image after the experiment. (C) Mouse neutrophils (MN) labeled with CFSE
(Neut, green arrows) attached to CP explant. (D) Comparison of DC and neutrophil (Neut) transmigration into the explant lumen during 24 h. Data are means ± SEM.
*p < 0.05 by Wilcoxon rank-sum test, n = 20.
to a medium without FBS, after 3 days the explant maintained
its original structure (Figure 5C), indicating the importance of
FBS for the early establishment of the explants. Using the same
culture medium combination, we tested lower Matrigel content
(20%) in plating suspension and found that explants were also
able to adapt to two-dimensional culture while still forming
‘‘lumens’’ (Figure 5D). After prolonged culture, explants in 50%
Matrigel increased in size and the cells assumed nearly columnar
morphology at day 12–18 and started to accumulated CD in the
lumen (Figure 5E).
Monitoring Immune Cell Interactions in CP
Explants
Next, we investigated the possibility of monitoring the
interactions of immune cells with CP explants. DCs are
professional effective antigen-presenting cells and play
important roles in immune surveillance of the brain together
with macrophages (McMenamin, 1999; Serot et al., 2000;
Meeker et al., 2012). Under normal circumstances, macrophages
and DCs migrate through the CP epithelial layer for immune
surveillance purposes, but these cells can also harbor infections,
such as pathogenic viruses (Meeker et al., 2012; Quintana et al.,
2015). DC transmigration is thought to play a particular role in
the pathogenesis of multiple sclerosis (Vercellino et al., 2008;
De Laere et al., 2018). Under pathological conditions, such
as brain injuries and infections, other immune cells, such as
neutrophils, cross through the CP and accumulate in the CSF
(Szmydynger-Chodobska et al., 2009; Kaur et al., 2016). As an
example of an interaction of immune cells with the CP epithelial
layer, we tested two immunocompetent cell types—activated
DCs and neutrophils, which have different capacities of traveling
inside the CP (Kaur et al., 2016). We added human DCs and MN
to CP explant cultures and monitored the immune cell migration
in the presence of the cytokines: IL1, IL6, and TNFα. During the
24 h incubation, DCs migrated towards explant cells, and some
of them migrated into the explant lumen (Figure 6A). To be
able to quantify DCs crossing the epithelial barrier, we labeled
the DCs with CFSE, a cell-permeable fluorescent cell staining
dye, and visualized their location inside of the lumen space
after 24 h (Figure 6B). MN also migrated towards the explants
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FIGURE 7 | CP explants as a model to study interactions with immune cells.
Comparison of architecture in native CP and CP explants. The graphical
elements were modified from SMART SERVIER MEDICAL ART, Les
Laboratoires Sevier.
and made contact with CP cells but very few of them were able
to penetrate and migrate inside (Figure 6D, Supplementary
Movie S1). Wilcoxon rank-sum test with continuity correction
resulted in a p-value = 0.04734. Considering the data and
actual shift in the mean of the distribution, a power of the
experiment can be simulated to be above 0.9 for the Wilcoxon
rank-sum test using the wmwpow package in R. These data
suggest that interactions of immune cells with CP epithelial
border and their transmigration can be determined in vitro in
the explant/organoid platform by microscopy.
DISCUSSION
Organoids as research platform is widely used for several
epithelial tissues, such as intestine, liver, thyroid and mammary
glands (Rossi et al., 2018). These systems mimic the structure
of the epithelium in situ due to embedding in a gel, resembling
an extracellular matrix (Takebe and Wells, 2019), which allows
the three-dimensional tissue formation. Here, we report an
in vitro platform for the generation of native CP fragment-
derived organoids, or explants. The term ‘‘organoid’’ is often
used with regards to stem cell generated cultures of native
tissue explants, capable of showing functional andmorphological
features of an organ (Fatehullah et al., 2016). In this study,
the CP explants/organoids were generated from dissociated
fragments of adult mouse CP, could be passaged and could
reorganize themselves and form a closed lumen. The explants
can be generated from individual mice, which makes it
advantageous compared to iPSC derived cerebral organoids.
Indeed, iPSC-derived organoids tend to resemble fetal tissues
and do not have the appropriate functionality of adult stem
cell-derived organoids (Takebe and Wells, 2019). The CP
explants mainly consist of one cell type, CP EC, without
contamination of blood vessels and fibroblasts, which makes
them a suitable model for gene expression studies. Furthermore,
as practice shows, the generation of cerebral organoids relies on
a long-term culture supplemented with expensive growth factors
(Lancaster and Knoblich, 2015), while this CP explant method
presented here is less expensive and time-consuming.
The three-dimensional culture conditions allow the cell lining
to form lumen, which makes immune cell transmigration studies
possible. Explants can be generated in various sizes, allowing the
system to be adapted for different kinds of microscopy. These
cultures can also be transformed into nearly monolayer cultures
for wide-field imaging after the primary explants have been
established. Thus, the flexibility of the system is another benefit
of CP explants compared to other culture systems, such as CP
epithelium monolayers and microspheres.
The choroidal explant cultures established from mouse CP
in this study display proper morphology and cell polarization.
Immunochemical studies demonstrated the presence of CP
markers: Ttr, a thyroxine transport protein exclusively produced
by the choroidal epithelia in the CNS, AQ-1, ZO1 and the
tight junction marker ICAM-1. Gene expression of transthyretin
and transferrin was maintained in explants at similar levels to
native CP, which indicates the ability of explants to secret CSF
products. Gene expression levels of Ptgds, which plays a role
in immune cell recruitment and maintenance of extracellular
matrix, were similar in CP explants and native CP. This is
important with regards to future modeling of pathophysiological
conditions in the explant system, such as multiple sclerosis.
Expression of AQ1, a water channel, on the apical side, indicates
the appropriate polarization of explant cells, supported by
F-actin staining. However, future studies, such as analysis of
produced and secreted proteins and appropriate expression
of receptors, are needed to address whether the functions of
secretion metabolic control and transport in CP explant cells
are similar to those in native CP. The ability of CP explants
to generate cyst-like lumens after plating in Matrigel and the
presence of tight junction markers ICAM-1, ZO1 and occludin
indicates that CP explant cells provide intact barrier function.
The detection of epithelial barrier impairment in the explants has
limitations when using a fluorescence dye in the lumen because
it is difficult to estimate the changes in fluorescence intensity
with high precision. Penetration of Evans Blue or dextran-based
dyes into the CP explant lumen from the culture medium can
be used to detect compromised epithelial barrier integrity. In
this study, we present a proof of principle for monitoring the
interaction of immune cells with CP cells. This opens a possibility
to study the behavior of various immune cells during pathogenic
processes, such as transport of viruses across the CP epithelial
barrier or nerve tissue damage in, for example, multiple sclerosis
by lymphocytes and monocytes migration across the barrier,
a process mediated by cytokines and facilitated by adhesion
molecules on the immune cells. Further studies are needed to
address whether all types of immune cells display their ‘‘normal’’
behavior towards CP cells in vitro, as well as determine which
proteins are secreted by the CP explants into the lumen, or how
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the cell membrane capacity is changing when cells are cultured
in vitro. In relevant studies, the integrity of CP epithelial barrier
and immune cell activity can be modified by the addition of, for
example, LPS or cytokines and complement proteins. Besides,
this system can potentially be used to test the drug’s ability to
cross the barrier or to induce its opening, to model disease by
increase inflammatory signaling.
The limitation of this system is the variability of explants
in size, and that large single luminal spaces are challenging
to generate and require several weeks to be formed. However,
this can be overcome by changing the cell culture regimes,
such as applying FBS and careful selection of additional growth
factors, which have been proven to improve the culture of some
organoid types (Fujii et al., 2018). Importantly, as with many
organoid systems (Rossi et al., 2018; Takebe and Wells, 2019),
the full identity of cells constituting CP is not determined,
and they develop in the artificially composed environment,
where they cannot benefit from systemic influences and factors
produced by neighboring tissues. It remains to be determined
to what extent the functions of EC resemble those in vivo.
However, although CP explants do not represent a full model
of BCSFB and cannot secrete full-fledged CSF, as they do not
have functioning blood vessels, our results show that they can
be used to test specific functions of CP epithelium, such as cell-
to-cell connections, gene expression profiling and expression
of proteins in different conditions. For example, in addition
to the applications mentioned in this study, the CP explant
model can be useful to study metabolic conditions and diseases,
such as aging, ischemia, Alzheimer’s disease, Parkinson’s disease,
and as already mentioned multiple sclerosis. These conditions
have been associated with impairment of CP secretory capacity,
amyloid clearance and barrier function, where the transport of
pathogenic particles is facilitated by changing properties of the
cell membrane, in addition to poorly controlled trafficking of
immune cells (for review, Cheng and Haorah, 2019). Disease
modeling using the CP explants can be applied for dissecting
the mechanisms of such impairment and identification of
regulatory components, such as structural proteins or receptors.
In this model, gene and protein profiles can be analyzed and
secreted products and growth factors can be detected in the
medium. Particular metabolic parameters, such as labeling of
mitochondria and their activity using voltage-sensitive dyes or
markers of ATP synthesis (Kant et al., 2018), could be also
accessed in the platform.
Thus, the CP explant model can be used to study the cellular
and molecular mechanisms mediating immune cell migration
through CP epithelium and other functions of CP. In perspective,
studies on the regulation of migratory behavior of immune cells
in CP can identify new therapeutic targets and develop strategies
to interfere with the recruitment of pathogenic immune cells to
the CNS.
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FIGURE S1 | (A) Retention of cell-permeable fluorescent dye CFSE (green) in the
lumen of a CP explant over time (bar 20 µm). (B) Mean fluorescence intensity over
the lumen area from CFSE loaded organoids (n = 8). Representative traces from
8 organoids during the same imaging experiment as shown in panel (A).
MOVIE S1 | This movie shows transmitted light time-lapse images of two
closely positioned mouse CP explants in Matrigel co-cultured with mouse
neutrophils, some of which migrate towards the explants. One of the neutrophils
repeatedly “investigates” the explant structures, but do not transmigrate inside.
The time-lapse covers 2 h. A similar experimental setup is also illustrated in
Figure 6C.
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